Renewal of Technology Licensee Agreement with BioLASCO Taiwan
May 30, 2011 - Research is global and the resources available to you should be as well. To ensure that you have the resources you need to advance your research globally, Charles River maintains a relationship with several key international partners.
We are pleased to announce the renewal of a Technology Licensee Agreement with an important international partner: BioLASCO Taiwan. Through this agreement, researchers collaborating on global studies can use standardized models as well as have global access to high-quality Charles River animal models.
BioLASCO has been a Research Models Technology Licensee of Charles River since 2001. At the start of the partnership they functioned primarily as a distributor. In 2005, they expanded to include rodent production. Their AAALAC-accredited facility in Yi-Lan, Taiwan, which serves the Taiwanese market as well as parts of Southeast Asia and China, currently produces mice and rats following Charles River standard operating procedures.
As a technology licensee, BioLASCO has the right to use the Charles River name and brand, produce animals sourced from Charles River, and have access to Charles River technology. We are delighted to have such a well-established and respected partner in Taiwan.
BioLASCO can be contacted at their Yi-Lan facility at +(88) 639 615839 or their Taiwan office at +(88) 622 6518669. They can also be contacted via their website at http://www.biolasco.com.tw/.
For additional information regarding Charles River Research Models and Services global partnerships, please click here.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Clinical pathology data can assist you in selecting the most appropriate model for your study and can provide important information on the physiology and health of your research animals.
We are now the exclusive distributor of the TARGATT™ mouse. The TARGATT mouse is a transgenic mouse designed to produce animal models with investigator designed exogenous DNA sequences knocked-in to a specific site.
Jun 10–Jun 13
Visit us in booth #091 to learn more about our recent innovations including expanded diagnostic capabilities, a new online portal connecting clients with their colonies and a deep-rooted commitment to humane care.
May 20–May 22
Please visit Charles River tabletop #611 to discuss our full portfolio of products and services, including our Preclinical Services, as well as our Biopharmaceutical Services, which deliver client-focused solutions for the specific testing and manufacturing requirements of your biologic.
May 23–May 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.